|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4641 USD | +1.11% |
|
-3.89% | -49.20% |
Anne Wojcicki, CEO and co-founder of 23andMe, talks about her partnership with Amazon for Prime Day and the benefits of understanding the human genome for consumer health. She also discusses the acquisition of Lemonaid Health, and her goal of becoming a leader in preventive medicine. Finally, she deciphers the promising results of her monoclonal antibody developed for the treatment of cancer.
(MT Newswires)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 2,686 PTS | +0.86% | +2.29% | - | ||
| 179.6 USD | +3.43% | +2.86% | 1,869B | ||
| 0.4641 USD | +1.11% | -3.89% | 224M | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -49.20% | 224M | |
| -17.89% | 8.25B | |
| +39.20% | 3.57B | |
| -39.11% | 2.46B | |
| -8.06% | 2.46B | |
| -7.35% | 2.38B | |
| -12.61% | 1.81B | |
| -19.01% | 1.55B | |
| -40.66% | 1.21B | |
| +7.56% | 1.11B |
23ANDME HOLDING CO. 
